This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
C. G. Ballard 2002. Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex. Consciousness and Cognition, 11, 461–474.
M. Doyle and D. Warden 1996. Use of SPECT to evaluate postcardiotomy delirium. American Journal of Psychiatry, 153, 838–839.
D. A. Drachman and J. Leavitt 1974. Human memory and the cholinergic system. A relationship to aging? Archives of Neurology, 30, 113–121.
M. P. Dunne and L. R. Hartley 1986. Scopolamine and the control of attention in humans. Psychopharmacology (Berlin), 89, 94–97.
M. Elie , M. G. Cole , F. J. Primeau and F. Bellavance 1998. Delirium risk factors in elderly hospitalized patients. Journal of General Internal Medicine, 13, 204–212.
J. D. Gaudreau and P. Gagnon 2005. Psychotogenic drugs and delirium pathogenesis: the central role of the thalamus. Medical Hypotheses, 64, 471–475.
J. J. Hagan , J. D. Salamone , J. Simpson , S. D. Iversen and R. G. Morris 1988. Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis. Behavioural Brain Research, 27, 9–20.
S. K. Inouye 1994. The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. American Journal of Medicine, 97, 278–288.
S. K. Inouye , J. T. Rushing , M. D. Foreman , R. M. Palmer and P. Pompei 1998. Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. Journal of General Internal Medicine, 13, 234–242.
S. Jacobson and H. Jerrier 2000. EEG in delirium. Seminars in Clinical Neuropsychiatry, 5, 86–92.
G. Koller 2003. Effects of scopolamine on matching to sample paradigm and related tests in human subjects. Neuropsychobiology, 48, 87–94.
B. Liptzin , A. Laki , J. L. Garb , R. Fingeroth and R. Krushell 2005. Donepezil in the prevention and treatment of post-surgical delirium. American Journal of Geriatric Psychiatry, 13, 1100–1106.
H. D. Mansvelder , K. I. van Aerde , J. J. Couey and A. B. Brussaard 2005. Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacology (Berlin), 184, 292–305.
J. McCusker , M. Cole , N. Dendukuri , L. Han and E. Belzile 2003. The course of delirium in older medical inpatients: a prospective study. Journal of General Internal Medicine, 18, 696–704.
I. McKeith (2000). Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. The Lancet, 356, 2031–2036.
D. J. Meagher 2001. Delirium: optimising management. BMJ, 322, 144–149.
D. J. Meagher 2007. Phenomenology of delirium. British Journal of Psychiatry, 190, 135–141.
J. L. Muir 1996. Attention and stimulus processing in the rat. Cognitive Brain Research, 3, 215–225.
J. L. Muir 1997. Acetylcholine, aging, and Alzheimer's disease. Pharmacology Biochemistry and Behaviour, 56, 687–696.
B. J. Naughton , S. Saltzman , F. Ramadan , N. Chadha , R. Priore and J. M. Mylotte 2005. A multifactorial intervention to reduce prevalence of delirium and shorten hospital length of stay. Journal of the American Geriatrics Society, 53, 18–23.
M. A. Noyan , H. Elbi and H. Aksu 2003. Donepezil for anticholinergic drug intoxication: a case report. Progress in Neuropsychopharmacology and Biological Psychiatry, 27, 885–887.
S. T. O'Keeffe 1999. Clinical subtypes of delirium in the elderly. Dementia and Geriatric Cognitive Disorders, 10, 380–385.
C. Paton 2002. Benzodiazepines and disinhibition: a review. Psychiatric Bulletin, 26, 460–462.
E. K. Perry and R. H. Perry 1995. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain and Cognition, 28, 240–258.
E. K. Perry , R. H. Perry , G. Blessed and B. E. Tomlinson 1978. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathology and Applied Neurobiology, 4, 273–277.
E. K. Perry 1994. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport, 5, 747–749.
E. Perry , M. Walker , J. Grace and R. Perry 1999. Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends in Neurosciences, 22, 273–280.
F. M. Reischies , A. H. Neuhaus , M. L. Hansen , S. Mientus , C. Mullert and J. Gallinat 2005. Electrophysiological and neuropsychological analysis of a delirious state: the role of the anterior cingulate gyrus. Psychiatry Research, 138, 171–181.
C. W. Ritchie , D. Ames , T. Clayton and R. Lai 2004. Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine and rivastigmine for the treatment of Alzheimer's disease. American Journal of Geriatric Psychiatry, 12, 358–369.
K. Rockwood 1994. Increasing the recognition of delirium in elderly patients. Journal of the American Geriatrics Society, 42, 252–256.
K. Rockwood , S. Cosway , D. Carver , P. Jarrett and K. Stadnyk 1999. The risk of dementia and death after delirium. Age and Ageing, 28, 551–556.
E. L. Sampson 2007. A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. International Journal of Geriatric Psychiatry, 22, 343–349.
L. S. Schneider , K. S. Dagerman and P. Insel 2005. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294, 1934–1943.
L. S. Schneider 2006. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525–1538.
J. D. Schor 1992. Risk factors for delirium in hospitalized elderly. JAMA, 267, 827–831.
D. Seto , W. H. Zheng , A. McNicoll , B. Collier , R. Quirion and S. Kar 2002. Insulin-like growth factor-I inhibits endogenous acetylcholine release from the rat hippocampal formation: possible involvement of GABA in mediating the effects. Neuroscience, 115, 603–612.
N. Slatkin and M. Rhiner 2004. Treatment of opioid-induced delirium with acetylcholinesterase inhibitors: a case report. Journal of Pain and Symptom Management, 27, 268–273.
G. H. Suh and A. Shah 2005. Effect of antipsychotics on mortality in elderly patients with dementia: a 1 year prospective study in a nursing home. International Psychogeriatrics, 17, 429–441.
P. T. Trzepacz , B. H. Mulsant , D. M. Amanda , R. Pasternak , R. A. Sweet and G. S. Zubenko 1998. Is delirium different when it occurs in dementia? A study using the delirium rating scale. Journal of Neuropsychiatry and Clinical Neurosciences, 10, 199–204.
L. Tune and J. T. Coyle 1980. Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Archives of General Psychiatry, 37, 293–297.
L. E. Tune and S. Egeli 1999. Acetylcholine and delirium. Dementia and Geriatric Cognitive Disorders, 10, 342–344.
L. Tune , S. Carr , E. Hoag and T. Cooper 1992. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. American Journal of Psychiatry, 149, 1393–1394.
D. M. Warburton and J. M. Rusted 1993. Cholinergic control of cognitive resources. Neuropsychobiology, 28, 43–46.
K. B. Zajicek , J. D. Higley , S. J. Suomi and M. Linnoila 1997. Rhesus macaques with high CSF 5-HIAA concentrations exhibit early sleep onset. Psychiatry Research, 73, 15–25.